PABLO
GUISADO VASCO
PROFESOR
![Foto de PABLO](/img/uploaded/CF50829333FAB8A9FA2B4553FA8F2102.jpg)
![Foto de Hospital Clínico San Carlos de Madrid](/img/noimage_org.png)
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clínico San Carlos de Madrid (7)
2023
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
-
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort
Journal of Clinical Medicine, Vol. 12, Núm. 3
2022
-
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
Life science alliance, Vol. 5, Núm. 4
2021
-
Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain
The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 76, Núm. 3, pp. e28-e37
2019
-
Safety and efficacy of prolonged use of dalbavancin in bone and joint infections
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5
2018
-
Dalbavancin in the treatment of different gram-positive infections: a real-life experience
International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577